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Abstract 
Tramadol is one of widest abused street drug in Egypt. Recently, drug abusers were taking tramadol beside sildenafil for 
sexual purposes.So it was important to develop a newHPLC method for the simaultineous determination of tramadol 
andSildenafil in the blood of rats exposed to a combination of specific dose of tramadol and sildenafil. Sample preparation 
involved liquid–liquid extraction with methyl tertiary butyl ether (MTBE) and backextraction with hydrochloric 
acid.Tramadol,sildenafiland the internalstandardnalbuphine were separated by reversed 
phaseHPLCusing60%acetonitrileand 40% 20mMsodium phosphate bufferpH 7.5. Detection was by using UV at 
wavelengths 230 nm. The method was linear fortramadol (0.8–100ug/ml) and Sildenafil (0.3–100 ug/ml) with mean 
recoveries of 97.2% and 100.8%, respectively. Intra- and inter-day precisionswere 9.34% and 9.12% for tramadol and 
11.82%, and10.43% for sildenafilat the respective limits of quantitation (0.8 and 0.3ug/ml). Accuracy fortramadol and 
Sildenafil ranged from 96.6% to 97.8%and 99.2% to 101.3% respectively. The method was applied to apharmacokinetic 
study of tramadol and sildenafil in rats. 
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Introduction 
Tramadol hydrochloride, (±)-Trans-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl) cyclohexanol (Fig. 1a), is acentrally-
acting analgesic used in the treatment of mild tomoderate pain (1). Its therapeutic plasma concentration range is100–300 
ng/ml (2). Tramadol is rapidly and almostcompletely absorbed after oral administration but its absolutebioavailability is only 
65–70% due to first-pass metabolism (3).The metabolism of tramadol in human is mediated bycytochrome P4502D6 
(CYP2D6) to O-desmethyltramadolODT) and N-desmethyltramadol (NDT). ODT ispharmacologically active and 
contributes to the analgesic efficacyof tramadol (4). 
Sildenafil ( 1- [[ 3 - ( 6,7 - dihydro - 1- methyl - 7 oxo - 3- propyl - 1H- pyrazolo [ 4,3-d] pyrimidine - 5 -yl ) - 4 - ethoxyphenyl 
] sulfonyl ] - 4- methyl piperazine (fig.1b) is a potent and selective inhibitor of cGMP - specific phosphodiesterase capable 
of enhencing the relaxation of the penile corpus covernosum and therefore having the potential improve penile erectile 
function. Quantification of sildenafil is essential during the evaluation of drug. Several HPLC methods have been 
developed for determination of sildenafil in various samples, such as dietary supplements (5-7), pharmaceutical 
preparation (8), and mouse skin (9), human plasma and urine (10,11,12). For a review see “Sildenafil determination in 
various matrices” (13) Analyses were based on liquid-liquid extraction at basic pH (6, 7). For this purpose we used this 
simple, rapid and accurate HPLC method  
 
Fig. 1a Chemical structures of Tramadol 
 
Fig. 1bChemical structures ofSildenafil 
Experimental 
Chemicals and reagents 
Pure Tramadol hydrochloridewas obtained from. Minapharm, Cairo, Egypt, Sildenafil citrate was obtained from Pfizer 
pharmaceutical company (Pfizer Ltd., Egypt),and Nalbuphine was obtained from AmounPharmaceuticalCo.El-ObourCity 
(Cairo-Egypt). Acetonitrile,Methanol and methyl tertiary butyl  ether (MTBE)  (HPLC grade) were purchased from 
Merck(Darmstadt, Germany). Deionized water was produced bya Milli-Q Millipore Water System (Milford, MA). 
Potassiumdihydrogen phosphate and sodium tetraborate decahydratewere from J.T. Baker (Deventer,Holland). All other 
reagents and materials were of analyticalgrade and supplied from commercial sources. The aqueous andorganic 
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components of the mobile phase, degassed under pressure,were mixed by the HPLC. The LC mobile phases were 
filteredthrough 0.2-mm cellulose acetate membrane filters(Sartorius Stedim Biotech S.A.; Aubagne Cedex, France) with 
asolvent filtration apparatus. 
Standard solutions 
Stock solutions of Tramadol, sildenafil and the internal standard nalbuphinewereprepared to a concentration of 1,000 
µg/mL in MeOH usingvolumetric flasks. These were then stored at –20C. To obtaina final concentration of 100 µg/mL, 
appropriate dilutions ofstock standard solutions were prepared by diluting 1 mL ofeach solution to 10 mL. These solutions 
of Tramadol, sildenafil and the internal standard nalbuphine were serially diluted in glass tubes (10 mL) to reachfinal 
concentrations of  5, 1, 0.5 and 0.1 µg/mL. Then they werestored at –20C  
Instrumentation and chromatographic conditions 
HPLC was performed an Agilant (USA) series1100 Quadrapump and Diode Array DETECTION. C18 5µm Ecilpse × DB 
column with particle size 5µm (150×4.6mm) was use The mobile phase consisted of 60% acetonitrile (A)–40% 20 Mm 
KH2PO4 buffer (B) adjusted to pH 7.5 with NaOH at a flow rateof 1.5 mL/min.  
Animal treatment and sampling 
Animal experiments were conducted at the animal experimentalfacility of the national researchcenter (Cairo-Egypt).Twenty 
fourWistar breed rats weighing 130 to 150 g were usedfor the experiment. The rats were randomly divided into eight 
groups consisting of three animals. These rats were housedtwo per cage, under conventional ventilation, temperature (18-
20°C) and lighting (16 h light/day) conditions. During thestudy, they were given free access to water and food. Thehealth 
of the rats was monitored daily by qualified personnelsupervised by aveterinarian for the duration of the study. Theanimals 
were given one week to adjust to their newenvironment before commencement of the experiment.During this adjustment 
period; all animals were kept on drugfreefeed. After the adjustment period, Group GI received asingle injection of saline 
while the other groups received acombination of Tramadol at 100 mg/kg and Sildenafil at 100 mg/kg; allinjections were 
given orally. The animal groupswere sacrificed after 30 min (GII), 1h (GIII), 2 (GIV), 4 h (GV), 6 h(GVI), 9 h (GVII) and 24 h 
(GVIII), respectively, following administration  
The animals were decapitated and the bloodsamples collected immediately. All samples were immediately frozen at–20°C 
until analysis . 
Sample extraction 
The procedure was performed in a 15-mL screw-capped polypropylenevial. A 1-mL aliquot of whole blood was added 
to300µL of IS (100µg/mL). After vortexing for 30 s, 0.5mL ofNa2B4O7 10H2O buffer (0.2M, pH 9.0) was added and 
thesample was vortexed again. Six mL of MTBE was then added,then the sample was vortexed (30 s), shaken (60 
osc/min,10 min) and centrifuged at 2,191 g (rotor radius 10 cm) for10 min. Five mL of the supernatant was collected in a 
cleanscrew-cappedpolypropylene vial containing 1 mL of 0.01MHCl. This latter blend was vortexed (30 s), shaken (60 
osc/min,5 min) and centrifuged at 2,191 g (rotor radius 10 cm) for5 min. The organic layer was discarded. The aqueous 
layer wasalkalinized with 0.5 mL of 0.2M borate buffer and the mixturewas extracted with 5 mL of MTBE by shaking for 5 
min followedby centrifugation at 2,191 g (rotor radius 10 cm) for 3 min. Four mL of organic layer was transferred to a 5-mL 
glasstube for complete evaporation in speed vacuum concentrator. The residue was reconstituted with 500 µL of amobile 
phase of acetonitrile–Phosphate buffer (10:90) and 100 µL was injected onto the HPLC. 
Bioanalytical method validation 
The described method was validated in terms of linearity, limitof detection (LOD), limit of quantification (LOQ), 
recovery,specificity, stability, precision and accuracy according to internationalguidelines on the bioanalytical method 
validation (14).Calibration curves were obtained by spiking the blank matrixwith a known concentration of each drug and 
Internal standard to provideconcentrations of 2.5, 5, 10, 30, 50, 70 and 100 µg/mL. The calibration curves of peak area 
versus concentration(µg/mL) of the investigated drugs were plotted. Least squares regressionparameters for the 
calibration curves were calculated, and theconcentrations of the test samples were interpolated from theregression 
parameters. Sample concentrations were determinedby linear regression, using the formula Y =mX +b, where Ypeak area, 
X concentration of the standard in mg/mL, mthe slope of the curve and b the intercept with Y axis.Correlation coefficients 
for each of the calibration curves were. 0.997Within-run and between-run accuracy and precision wereassessed on quality 
control samples (QC samples) and determinedby replicate analysis using seven determinations of differentconcentration 
levels: LOQ (0.8µg/mL; 0.3µg/mL for Tramadol and sildenafil), low QC (2.5 and 5µg/mL), medium QC (10 and 30µg/mL) 
and high QC (100 µg/mL). 
Quantification 
When unknown samples were assayed, a control and a fortifiedblank sample were processed simultaneously for 
qualitycontrol. LODs and LOQs were determined as analyte concentrationsgiving signal-to-noise ratios of 3 and 10, 
respectively. 
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Statistical analysis and pharmacokinetic analysis 
The statistical analyses were evaluated using an analysis of variance (ANOVA) test. The results were presented as 
mean± standard deviation (SD). All the analyses were conducted using GraphPad InStat (GraphPad Software; La Jolla, 
CA). For all the experiments, differences were considered significant if the associated probability level (P) was lower than 
0.05. The pharmacokinetic calculations were carried out using WinNonLin v 5.2.1 (Pharsight Corp.; Sunnyvale, CA). 
Maximum concentration(Cmax) for all the investigated drugs in blood and the time required to reach Cmax (Tmax) were 
predicted from the data. Changes in blood concentrationsfor all the investigated drugs were evaluated using the standard 
non-compartmental analysis and the relative pharmacokinetic parameters were determined using 
standardoncompartmentalequations. 
Results and Discussion 
Detection method development 
The mobile phase was chosen on the basis of a previously published method. The Phosphate buffer was tested at 
different concentrations (0.01, 0.02, 0.05 and 0.1M). At the lower concentration, Tr and IS resulted in the same retention 
time. The investigated drugs were well separated from blood impurities at buffer concentrations of 0.02, 0.05 and 0.1M, 
and 0.02M was chosen as optimal because higher concentrations can cause salt precipitation in the HLPC. A range of 
buffer pH (3.0 to 8) was assayed to optimize the chromatographic separation. Optimal peak separation for pure 
investigated drugs was produced using a pH ranging between 7 and 8, but the actual working is  pH 7.5. The final mobile 
phase resulted in acetonitrile–NaH2PO4 (0.02M), pH 7.5 with a 1.5 mL/min flow rate. This was found to be an excellent 
compromise in terms of sensitivity and peak separation. The wavelengths tested in the present study were: 275 nm (15) 
,225 nm (16) and 290 nm (17).  The wavelength value of 230 nm was found to beoptimal in terms of sensitivity for all the 
investigated drugs and avoidingseveral matrix impurities that became problematic at lowerwavelengths. 
The Internal standard was chosen based on previous studies on Tramadol. 
Optimization of the extraction condaitions 
The influence of the kind of solvents (an important tool for the selectivity of the method) was studied to find the optimal 
extraction protocol for the investigated drugs. The solvents ethylacetate (20,18), MTBE (19) and chloroform (commonly 
used in the Forensic Toxicology Lab; Cairo, Egypt) were compared. MTBE was selected as the most suitable organic 
solvent in terms of analyte extraction and minimization of matrix interference (Table I). Optimal pH value for extraction was 
9. 
Table I 
Single Extraction Recovery Percent (±SD) of Tramadol, sildenafil and IS Spiked at 20µg/mL with Different Organic 
Solvents (n = 3) 
Organic solvents Tramadol sildenafil IS 
Ethylacetate 85.1±5.4 76.5±6.4 25.2±2.4 
Chloroform 80.4±4.4 45.3±3.7 81.1±5.2 
MTBE 97.2±6.39 100.8±5.33 99.8±3.5 
 
Method validation 
It was found that there were no published methodologies for simultaneous determination of Tramadol, Sildenafil and 
Intrnal standard from rat blood samples using HPLC–UV,so it was  necessary to validate each step of the suggested 
analytical method.The calibration curves were constructed by plotting the ratioof the peak areas versus concentrations in 
the working range.Good linearity was achieved for Tramadol and sildenafil in therange studied. The linear regression 
equations are reported inTable II.According to Europea Medicine Evaluation Agency (EMEA) guidelines (14), LODs and 
LOQs were calculated based on a signal-to-noise approach. These calculationswere performed by comparing measured 
signals fromsamples with known low concentrations of investigated drugs with thoseof blank samples. In this way, the 
minimum concentration atwhich the investigated drugs can be reliably quantified (LOQ) or detected(LOD) was determined. 
The typical signal-to-noise ratios were10:1 and 3:1 for LOQ and LOD, respectively (Table II). Boththe accuracy and the 
precision of these values lay within theproposed criteria [relative standard deviation (RSD), 20%].Specificity and 
interference by co-eluting components weredetermined by comparing the chromatograms of differentbatches of blank 
matrices to those from spiked whole bloodand test samples. It was found that under optimized chromatographicconditions, 
peaks due to the matrix did not interferewith Tramadol ,sildenafil and IS. Typical retention times forTramadol ,sildenafil and 
IS were 2.8+0.2, 1.7+0.05and 2.2+0.05 min, respectively (Figures 2A,2B and 2C).Recoveries were 97.2±6.39 % for 
Tramadol, 100.8±5.33% forsildenafil and 99.8±3.5% for IS.The respective coefficient of variation (CV) (%) values 
variedfrom 3.48to9.34, 5.33to11.82  and1.06 to 4.41 for Tramadol ,sildenafil and IS, respectively. Intra-dayvalue 
consistency (repeatability) was evaluated for five replicatesof each QC sample during the same day. Inter-day 
valueconsistency (intermediate precision) was evaluated by quantizationof Tramadol ,sildenafil and IS in QC samples on 
five differentdays. Relative errors for both the intra-day and inter-dayaccuracy were, 7%.Stability studies were performed 
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to ensure good reproducibilityof the method. Stock solutions of the investigated drugs and IS(10 µg/mL) and high and low 
QC samples were tested for stabilityunder short-term room temperature conditions, longtermstorage conditions (–20°C) 
and freeze-thaw treatment. Tramadol ,sildenafiland IS were very stable at both 20°C for 24 h and–20°C for 30 days. Data 
obtained after three freeze-thaw cycles showed that the investigated drugswere stable in rat blood (CV, 7%). These 
findingsindicated that the storage of investigated drugs in blood samples at–20°C is adequate, and no stability-related 
problems would beexpected during routine analyses for analytical studies within10 days.Robustness of the methodology 
was determined by the reproducibility of results using the (analytical) method in 20°C; a loss of 10–12% was observed 
anddifferent laboratories or under different circumstances. Thepresent study evaluated three blood aliquots from the 
treatedrats in two different labs (Faculty of science, Al-AzharUniversity, andChemistry Lab., Forensic Medicine 
Authority,Cairo, Egypt.) andobtained variations of less than 7.2%.These results demonstrate that the method enables 
accuratequantification of Tramadol and sildenafil. The validation parameterswere in agreement with the EMEA guidelines 
(14).Although to the best of our knowledge, no simultaneous detectionof, Tramadol and sildenafil in rat blood ispresent in 
the literature, the present findings are in line withprevious HPLC studies (critical in forensic medicine), takinginto 
consideration the singular investigated drugs (17,21,22,23).  
Table II Validation Data for Tramadol and sildenafil 
Parameter Tramadol sildenafil 
Linear range (µg/mL) 0.8-100 0.3-100 
Calibration equation y = - 0.0087 + 0.0269 x 
 
y = 0.778 + 0.0649 x 
 
Correlation coefficient (r2) 0.997 0.997 
Recovery (%) 97.2±6.39 100.8±5.33 
LOQ (µg/mL) 0.8 0.3 
LOD (µg/mL) 0.3 0.1 
Accuracy (%) 96.6-97.8 99.2-101.3 
Precision (%)   
Intra-day 3.48-9.34 5.33-11.82 
Inter-day 3.8-9.12 5.41-10.43 
Specificity Specific Specific 
 
Application of the method 
The applicability of this method was verified by determining Tramadol and Sildenafil in rat blood samples after oral 
administration of a combination of Tramadol and Sildenafil. HPLC analysis ofthe blood confirmed the presence of 
Tramadol and Sildenafil in time-related amounts (Figure 3). The amount of Tramadol and Sildenafil in blood ranged 
between 0.38 and 12.31µg/mL and 2.3 and 9.55µg/mL, respectively. The described method allowed the pharmacokinetics 
of the four investigated drugs to be followed. Tramadol and Sildenafil had a Cmax after 1 h. Tmax of Tramadol and 
Sildenafil are also in line with a recent pharmacokinetic study on rats (24). For this reason and others, because the 
present data have been derived using only two rats for each collection time, a large-scale study is indicated to fully 
determine the significance of the results. This method could also be applied to the detection of Tramadol and Sildenafil in 
pharmaceutical preparations. 
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(Fig 2 a): chromatographic curve from pure substances and IS (25 µg/mL), 
 
(Fig 2 b): chromatographic curve from fortified sample (2, 5 µg/mL) of Wistar rat blood 
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(Fig 2 c): chromatographic curve from blood sample collected from Wistar rat orally injected with a combination of 
tramadol (100 mg/kg) and sildenafil (100 mg/kg) (collection at 60 min). 
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(Fig 3a) 
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(Fig 3b) 
Figure 3 a,b: HPLC analysis of the blood confirmed the presence of Tramadol and Sildenafil in time-related amounts. 
Conclusion 
The described analytical method provides selective and accurate determination of Tramadol and Sildenafil without the 
need for expensive cleanup steps, solvent-consuming flows or expensive devices. The LOQs are within acceptable limits 
which is matched with therapeutic does and show that the method could be useful for forensic toxicological analysis on 
abusers. 
These features also make the described method suitable for pharmacokinetic investigations, including drug–drug 
interaction. In summary, this is the first time that 
HPLC–UV technique has been reported to simultaneously detect of Tramadol and Sildenafil. This method (extraction, 
separation and applied techniques) is simple precise, accurate, and efficacious for the determination of investigated drugs 
in rat blood and pharmaceutical preparations. 
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